Back to Search
Start Over
COVID-19 vaccination in patients with α1-antitrypsin deficiency.
- Source :
-
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Aug; Vol. 9 (8), pp. 818-820. Date of Electronic Publication: 2021 Jun 18. - Publication Year :
- 2021
-
Abstract
- Competing Interests: CY is a former postdoctoral fellow at the University Health Network. HZ declares no competing interests.
- Subjects :
- Canada
Humans
Immunity, Active immunology
Patient Acceptance of Health Care statistics & numerical data
Pulmonary Disease, Chronic Obstructive etiology
Pulmonary Disease, Chronic Obstructive therapy
SARS-CoV-2
Symptom Flare Up
alpha 1-Antitrypsin metabolism
COVID-19 epidemiology
COVID-19 prevention & control
COVID-19 Vaccines therapeutic use
Communicable Disease Control methods
Vaccination methods
Vaccination statistics & numerical data
alpha 1-Antitrypsin Deficiency epidemiology
alpha 1-Antitrypsin Deficiency immunology
alpha 1-Antitrypsin Deficiency physiopathology
alpha 1-Antitrypsin Deficiency therapy
Subjects
Details
- Language :
- English
- ISSN :
- 2213-2619
- Volume :
- 9
- Issue :
- 8
- Database :
- MEDLINE
- Journal :
- The Lancet. Respiratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 34147141
- Full Text :
- https://doi.org/10.1016/S2213-2600(21)00271-X